Lineage Cell Therapeutics, Inc. ( LCTX) - Stock Earnings
LCTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -29.8 million USD | 3.7 million USD |
| 2025Q4 | 851000 USD | 6.6 million USD |
| 2026Q1 | -4.8 million USD | 1.7 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
LCTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -21.5 million USD | 8.9 million USD |
| 2024 | -18.6 million USD | 9.5 million USD |
| 2025 | -63.5 million USD | 14.6 million USD |
| 2026 Est. | — | — |
LCTX
Price: $1.21
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.29 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 400600
Market Capitalization: 299.2 million